The prevention of the two most common types of skin cancer and pre-cancers is possible by taking an inexpensive, widely available, oral pill twice daily. Vitamin B3 , a supplement called nicotinamide, cut the rate of new squamous cell and basal cell carcinoma by 23% among patients who were at high risk for the development of skin cancer. Nicotinamide also reduced the risk for developing actinic keratosis, a common pre-cancer of the skin.
Who should take this?
Those who have had basal cell or squamous cell carcinoma, multiple actinic keratosis, or transplant patients may benefit from taking 500mg of nicotinamide twice daily. Speak with your provider if you have any questions.